Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Jody Bonnevier has 1 pending office action within the Biotechnology & Pharmaceuticals technology area. This workload is handled by 1 distinct examiner in a distinct art unit, showing a singular point of contact within the USPTO. Such a focused prosecution profile simplifies the tracking of deadlines and examiner interactions.
BELLECOURT, MICHAEL JOHN ALLEN serves as the busiest examiner with the busiest examiner pending office action. With only this examiner involved in the company's active prosecution, the relationship with this individual is the primary factor in the portfolio's advancement. Understanding the examiner's history in the biotechnology sector may provide insights into the likely trajectory.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| BELLECOURT, MICHAEL JOHN ALLEN | 1 | — | — |
| Art Unit | Apps |
|---|---|
| 1671 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18286852 | CAMELID ANTI-SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS ANTIBODIES | BELLECOURT, MICHAEL JOHN ALLEN | 1671 | §112 | Non-Final OA | — | Pending | Oct 13, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialJody Bonnevier has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Michael John Allen Bellecourt has the most, with 1 of Jody Bonnevier's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
